TY - JOUR
T1 - Early and long-term outlook of percutaneous coronary intervention for bifurcation lesions in young patients
AU - Roversi, Sara
AU - Biondi-Zoccai, Giuseppe
AU - Romagnoli, Elisa
AU - Sheiban, Imad
AU - De Servi, Stefano
AU - Tamburino, Corrado
AU - Colombo, Antonio
AU - Burzotta, Francesco
AU - Presbitero, Patrizia
AU - Bolognese, Leonardo
AU - Paloscia, Leonardo
AU - Rubino, Paolo
AU - Rubino, Pasquale
AU - Sardella, Gennaro
AU - Briguori, Carlo
AU - Niccoli, Luigi
AU - Franco, Gianfranco
AU - Glieca, Franco
AU - Di Girolamo, Domenico
AU - Piatti, Luigi
AU - Greco, Cesare
AU - Petronio, Sonia
AU - Loi, Bruno
AU - Lioy, Ernesto
AU - Benassi, Alberto
AU - Patti, Aldo
AU - Gaspardone, Achille
AU - Capodanno, Davide
AU - Modena, Maria Grazia
AU - Sangiorgi, Giuseppe
PY - 2013
Y1 - 2013
N2 - Background: Coronary artery disease is most common in older patients, but may occur in younger subjects. The outlook of young patients after percutaneous coronary intervention (PCI) of challenging lesion subsets such as coronary bifurcations, is not established. We thus aimed to appraise the early and long-term results of PCI for bifurcations in young patients. Methods: A multicenter, retrospective study was conducted enrolling consecutive patients undergoing bifurcation PCI between 2002 and 2006 in 22 Italian centers. Patients were divided in 2 groups: age ≤ 45 years, and age > 45 years. The primary end-point was long-term rate of major adverse cardiac events (MACE). Results: 4,314 patients were included: 195 (4.5%) in the younger group, and 4119 (95.5%) in the older group. 30-day outcomes did not show significant differences in MACE rates, with 1.0% in the ≤ 45 years group and 2.1% in the > 45 years group (p = 0.439), with death in 0.5% and 1.2% (p = 0.388). At long-term follow-up (24.4 ± 15.1 months), younger patients showed similar rates of MACE, (12.8% vs. 16.6%, p = 0.161), myocardial infarction (3.1% vs. 3.7%, p = 0.633), target lesion revascularization (11.3% vs. 12.5%, p = 0.627), or stent thrombosis (1.5% vs. 2.8%, p = 0.294), despite an increased risk of death in older patients (1.0% vs. 5.0%, p = 0.012). Even at extensive multivariable analysis, younger patients still faced a similar risk of MACE (HR = 0.78 [0.48-1.27], p = 0.318). Conclusions: Despite their low age, young patients undergoing PCI for bifurcation face a significant risk of early and late non-fatal adverse events. Thus, they should not be denied careful medical management and follow-up. © 2012 Elsevier Ireland Ltd.
AB - Background: Coronary artery disease is most common in older patients, but may occur in younger subjects. The outlook of young patients after percutaneous coronary intervention (PCI) of challenging lesion subsets such as coronary bifurcations, is not established. We thus aimed to appraise the early and long-term results of PCI for bifurcations in young patients. Methods: A multicenter, retrospective study was conducted enrolling consecutive patients undergoing bifurcation PCI between 2002 and 2006 in 22 Italian centers. Patients were divided in 2 groups: age ≤ 45 years, and age > 45 years. The primary end-point was long-term rate of major adverse cardiac events (MACE). Results: 4,314 patients were included: 195 (4.5%) in the younger group, and 4119 (95.5%) in the older group. 30-day outcomes did not show significant differences in MACE rates, with 1.0% in the ≤ 45 years group and 2.1% in the > 45 years group (p = 0.439), with death in 0.5% and 1.2% (p = 0.388). At long-term follow-up (24.4 ± 15.1 months), younger patients showed similar rates of MACE, (12.8% vs. 16.6%, p = 0.161), myocardial infarction (3.1% vs. 3.7%, p = 0.633), target lesion revascularization (11.3% vs. 12.5%, p = 0.627), or stent thrombosis (1.5% vs. 2.8%, p = 0.294), despite an increased risk of death in older patients (1.0% vs. 5.0%, p = 0.012). Even at extensive multivariable analysis, younger patients still faced a similar risk of MACE (HR = 0.78 [0.48-1.27], p = 0.318). Conclusions: Despite their low age, young patients undergoing PCI for bifurcation face a significant risk of early and late non-fatal adverse events. Thus, they should not be denied careful medical management and follow-up. © 2012 Elsevier Ireland Ltd.
KW - Adult
KW - Age
KW - Age Factors
KW - Aged
KW - Bifurcation
KW - Coronary Artery Disease
KW - Coronary artery disease
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Percutaneous Coronary Intervention
KW - Percutaneous transluminal coronary angioplasty
KW - Retrospective Studies
KW - Stent
KW - Time Factors
KW - Treatment Outcome
KW - Adult
KW - Age
KW - Age Factors
KW - Aged
KW - Bifurcation
KW - Coronary Artery Disease
KW - Coronary artery disease
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Percutaneous Coronary Intervention
KW - Percutaneous transluminal coronary angioplasty
KW - Retrospective Studies
KW - Stent
KW - Time Factors
KW - Treatment Outcome
UR - http://hdl.handle.net/10807/158371
U2 - 10.1016/j.ijcard.2012.09.005
DO - 10.1016/j.ijcard.2012.09.005
M3 - Article
SN - 0167-5273
VL - 167
SP - 2995
EP - 2999
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -